Literature DB >> 14593063

Small risk ratios may have strong public health impact.

Alfonso Carvajal, Miguel Angel Maciá, Javier García del Pozo, Francisco de Abajo.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 14593063      PMCID: PMC261708          DOI: 10.1136/bmj.327.7422.1050-c

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  4 in total

1.  Hepatotoxicity associated with nimesulide: data from the Spanish Pharmacovigilance System.

Authors:  Miguel Angel Maciá; Alfonso Carvajal; Javier García del Pozo; Ernesto Vera; Ana del Pino
Journal:  Clin Pharmacol Ther       Date:  2002-11       Impact factor: 6.875

2.  Fatal hepatoxicity secondary to nimesulide.

Authors:  G Merlani; M Fox; H P Oehen; G Cathomas; E L Renner; K Fattinger; M Schneemann; G A Kullak-Ublick
Journal:  Eur J Clin Pharmacol       Date:  2001-07       Impact factor: 2.953

3.  Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs.

Authors:  L A García Rodríguez; C Cattaruzzi; M G Troncon; L Agostinis
Journal:  Arch Intern Med       Date:  1998-01-12

4.  Cohort study of hepatotoxicity associated with nimesulide and other non-steroidal anti-inflammatory drugs.

Authors:  Giuseppe Traversa; Clara Bianchi; Roberto Da Cas; Iosief Abraha; Francesca Menniti-Ippolito; Mauro Venegoni
Journal:  BMJ       Date:  2003-07-05
  4 in total
  2 in total

1.  Nimesulide-induced hepatotoxicity in a previously healthy woman.

Authors:  L Gallelli; M Ferraro; G F Mauro; S De Fazio; G De Sarro
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

2.  Converting a microarray signature into a diagnostic test: a trial of custom 74 gene array for clarification and prediction the prognosis of gastric cancer.

Authors:  Ying Yin; Wei Zhuo; Yuan Zhao; Shujie Chen; Jun Li; Lan Wang; Tianhua Zhou; Jian-Min Si
Journal:  PLoS One       Date:  2013-12-03       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.